Icecure Selling General Administrative from 2010 to 2024

ICCM Stock  USD 0.76  0.02  2.70%   
Icecure Medical Selling General Administrative yearly trend continues to be very stable with very little volatility. Selling General Administrative is likely to grow to about 7.8 M this year. During the period from 2010 to 2024, Icecure Medical Selling General Administrative quarterly data regression pattern had sample variance of 6 T and median of  1,299,458. View All Fundamentals
 
Selling General Administrative  
First Reported
2010-12-31
Previous Quarter
7.4 M
Current Value
7.8 M
Quarterly Volatility
2.4 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Icecure Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Icecure Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 339.1 K, Interest Expense of 120.2 K or Selling General Administrative of 7.8 M, as well as many indicators such as Price To Sales Ratio of 14.37, Dividend Yield of 0.0 or PTB Ratio of 4.22. Icecure financial statements analysis is a perfect complement when working with Icecure Medical Valuation or Volatility modules.
  
Check out the analysis of Icecure Medical Correlation against competitors.
To learn how to invest in Icecure Stock, please use our How to Invest in Icecure Medical guide.

Latest Icecure Medical's Selling General Administrative Growth Pattern

Below is the plot of the Selling General Administrative of Icecure Medical over the last few years. It is Icecure Medical's Selling General Administrative historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Icecure Medical's overall financial position and show how it may be relating to other accounts over time.
Selling General Administrative10 Years Trend
Slightly volatile
   Selling General Administrative   
       Timeline  

Icecure Selling General Administrative Regression Statistics

Arithmetic Mean2,568,281
Geometric Mean1,852,942
Coefficient Of Variation95.39
Mean Deviation1,981,663
Median1,299,458
Standard Deviation2,449,976
Sample Variance6T
Range6.8M
R-Value0.78
Mean Square Error2.5T
R-Squared0.62
Significance0.0005
Slope429,989
Total Sum of Squares84T

Icecure Selling General Administrative History

20247.8 M
20237.4 M
20225.9 M
20214.1 M
20201.8 M
20191.3 M
20181.1 M

About Icecure Medical Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Icecure Medical income statement, its balance sheet, and the statement of cash flows. Icecure Medical investors use historical funamental indicators, such as Icecure Medical's Selling General Administrative, to determine how well the company is positioned to perform in the future. Although Icecure Medical investors may use each financial statement separately, they are all related. The changes in Icecure Medical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Icecure Medical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Icecure Medical Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Icecure Medical. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Selling General Administrative7.4 M7.8 M

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Icecure Medical using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Information and Resources on Investing in Icecure Stock

When determining whether Icecure Medical is a strong investment it is important to analyze Icecure Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Icecure Medical's future performance. For an informed investment choice regarding Icecure Stock, refer to the following important reports:
Check out the analysis of Icecure Medical Correlation against competitors.
To learn how to invest in Icecure Stock, please use our How to Invest in Icecure Medical guide.
You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Icecure Medical. If investors know Icecure will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Icecure Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.32)
Revenue Per Share
0.071
Quarterly Revenue Growth
0.337
Return On Assets
(0.42)
Return On Equity
(0.78)
The market value of Icecure Medical is measured differently than its book value, which is the value of Icecure that is recorded on the company's balance sheet. Investors also form their own opinion of Icecure Medical's value that differs from its market value or its book value, called intrinsic value, which is Icecure Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Icecure Medical's market value can be influenced by many factors that don't directly affect Icecure Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Icecure Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Icecure Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Icecure Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.